Treatment of <i>Candida glabrata</i> Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
ABSTRACT While Candida albicans remains the most common Candida isolate, Candida glabrata accounts for approximately 15 to 20% of all Candida infections in the United States. In this study we used immunosuppressed mice infected with C. glabrata to investigate the efficacy of liposomal amphotericin B...
Gardado en:
Main Authors: | Jon Olson, Jill Adler‐Moore, Peter J. Smith, Richard T. Proffitt |
---|---|
Formato: | Artigo |
Idioma: | inglés |
Publicado: |
2005
|
Acceso en liña: | https://doi.org/10.1128/aac.49.12.4895-4902.2005 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
por: Olson, Jon A., et al.
Publicado: (2005) -
Caspofungin in Combination with Amphotericin B against Candida glabrata
por: Barchiesi, Francesco, et al.
Publicado: (2005) -
Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii
por: Cantón, Emilia, et al.
Publicado: (2006) -
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
por: Yamada, Shoko Merrit, et al.
Publicado: (2016) -
Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
por: Healey, Kelley R., et al.
Publicado: (2011)